DJ-927 as Second-Line Therapy in Treating Patients With Progressive Locally Advanced or Metastatic Colorectal Adenocarcinoma

ABSTRACT: RATIONALE: Drugs used in chemotherapy, such as DJ-927, work in different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: This phase II trial is studying how well DJ-927 works as second-line therapy in treating patients with progressive locally advanced or metastatic colorectal adenocarcinoma (cancer).

DISEASE(S): Adenocarcinoma,Colorectal Cancer

PROVIDER: 2010661 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR